Molecular imaging and targeted therapies.
Targeted therapeutic and imaging agents are becoming more prevalent, and are used to treat increasingly smaller segments of the patient population. This has lead to dramatic increases in the costs for clinical trials. Biomarkers have great potential to reduce the numbers of patients needed to test novel targeted agents by predicting or identifying non-response early-on and thus enriching the clinical trial population with patients more likely to respond. Biomarkers are characteristics that are objectively measured and evaluated as indicators of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Biomarkers can be used to predict response to specific therapies, predict response regardless of therapy, or to monitor response once a therapy has begun. In terms of drug development, predictive biomarkers have the greatest impact, as they can be used as inclusion criteria for patient segmentation. Prognostic markers are used routinely in clinical practice but do not provide direction for the use of targeted therapies. Imaging biomarkers have distinct advantages over those that require a biopsy sample in that they are "non-invasive" and can be monitored longitudinally at multiple time points in the same patient. This review will examine the role of functional and molecular imaging in predicting response to specific therapies; will explore the advantages and disadvantages of targeting intracellular or extracellular markers; and will discuss the attributes of useful targets and methods for target identification and validation.
Morse
David L
DL
H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive SRB-2, Tampa, FL 33612, United States.
Gillies
Robert J
RJ
D014408:Biomarkers, Tumor / Q000378:metabolism*; D017930:Genes, Reporter; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism*
D014408:Biomarkers, Tumor
J Clin Oncol. 2004 Mar 1;22(5):785-94
14990633
Neuro Oncol. 2009 Dec;11(6):861-70
19401596
J Magn Reson Imaging. 2009 Dec;30(6):1233-5
19938034
Annu Rev Pharmacol Toxicol. 2001;41:347-66
11264461
Curr Opin Immunol. 2006 Apr;18(2):220-5
16460921
Cancer. 2009 Feb 1;115(3):581-6
19117348
Curr Pharm Biotechnol. 2004 Dec;5(6):509-18
15579040
J Am Chem Soc. 2009 Dec 9;131(48):17591-6
19860409
Electrophoresis. 2009 Dec;30(23):3998-4007
19960464
Cancer Res. 2009 May 15;69(10):4510-6
19417132
Clin Cancer Res. 2005 Aug 15;11(16):6030-9
16115948
Proc Natl Acad Sci U S A. 1986 Sep;83(17):6622-6
2428037
Clin Pharmacol Ther. 2001 Mar;69(3):89-95
11240971
Science. 2009 May 8;324(5928):804-7
19423828
Bioconjug Chem. 2007 Jul-Aug;18(4):1131-9
17488066
Adv Anat Pathol. 2004 Jul;11(4):211-20
15220824
JAMA. 2003 Oct 22;290(16):2149-58
14570950
Eur J Pharm Biopharm. 2009 Mar;71(3):409-19
19070661
Gan To Kagaku Ryoho. 2005 Oct;32(11):1546-9
16315864
Mol Cell Proteomics. 2008 Dec;7(12):2464-74
18678562
J Cell Biochem. 2009 Sep 1;108(1):3-9
19507229
J Immunol. 2002 Apr 15;168(8):3771-6
11937528
Nat Med. 2005 Mar;11(3):312-9
15711557
Adv Exp Med Biol. 2003;527:27-35
15206713
Semin Nucl Med. 2007 Nov;37(6):451-61
17920352
Cancer Res. 2006 Nov 15;66(22):10855-60
17108122
J Cereb Blood Flow Metab. 2006 Mar;26(3):345-57
16079785
J Med Chem. 2005 Feb 24;48(4):1098-106
15715477
J Nucl Med. 2006 Jul;47(7):1153-60
16818950
Chem Rev. 2010 May 12;110(5):3146-95
20225900
J Clin Oncol. 2003 Jun 15;21(12):2237-46
12748244
World J Surg. 2008 Jun;32(6):1057-66
18264829
Int J Cancer. 2010 Aug 1;127(3):729-36
19960440
Annu Rev Biomed Eng. 2005;7:287-326
16004573
Magn Reson Med. 2009 Aug;62(2):488-99
19466747
Clin Cancer Res. 2006 Feb 15;12(4):1144-51
16489067
Acad Radiol. 2010 Mar;17(3):382-6
20004597
Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1209-15
19327904
Expert Opin Biol Ther. 2010 May;10(5):711-24
20214497
Cancer Metastasis Rev. 2008 Dec;27(4):655-64
18523731
Pharm Res. 2007 Jun;24(6):1172-85
17385018
Contrast Media Mol Imaging. 2006 May-Jun;1(3):106-12
17193686
Mol Imaging Biol. 2006 Jul-Aug;8(4):226-36
16791749
Eur Radiol. 2007 Apr;17(4):861-72
17043737
Magn Reson Med. 2008 Aug;60(2):253-7
18666104
Nat Clin Pract Oncol. 2008 Apr;5(4):220-33
18301415
Radiology. 2007 Nov;245(2):333-56
17940297
Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17898-903
19815528
Am J Surg. 2007 Oct;194(4 Suppl):S84-6
17903452
Org Biomol Chem. 2006 May 21;4(10):1887-95
16688334
Neoplasia. 2005 Apr;7(4):390-6
15967116
Science. 2004 Jun 4;304(5676):1497-500
15118125
J Urol. 2004 Nov;172(5 Pt 2):S18-21; discussion S21-2
15535437
Neoplasia. 2008 Aug;10(8):745-56
18670636
Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):19801-6
19903889
Magn Reson Imaging. 2007 Apr;25(3):319-27
17371720
Technol Cancer Res Treat. 2008 Apr;7(2):149-54
18345704
J Nucl Med. 2001 May;42(5 Suppl):1S-93S
11483694
Radiology. 2009 Jul;252(1):182-9
19561256
Nat Rev Cancer. 2010 Jan;10(1):9-22
20029421
Mol Biosyst. 2009 Nov;5(11):1279-91
19823742
Mol Imaging Biol. 2010 Oct;12(5):488-99
19960268
J Nucl Med. 2009 Mar;50(3):356-63
19223408
J Gastroenterol Hepatol. 2004 Mar;19(3):319-26
14748880
Int J Radiat Oncol Biol Phys. 1989 Nov;17(5):985-91
2808061
Mol Pharm. 2009 Jul-Aug;6(4):1041-51
19366234
Radiology. 2006 Dec;241(3):892-8
17114630
J Exp Med. 1999 May 3;189(9):1363-72
10224276
Eur J Nucl Med Mol Imaging. 2009 Jun;36(6):947-57
19159928
Mol Cancer Ther. 2007 Apr;6(4):1186-97
17406031
Eur J Nucl Med Mol Imaging. 2003 Feb;30(2):207-16
12552338
Br J Radiol. 2009 Jan;82(973):28-34
19095814
Nanomedicine (Lond). 2008 Oct;3(5):703-17
18817471
J Drug Target. 2009 Jul;17(6):459-67
19527117
Dis Markers. 2002;18(2):41-6
12364809
J Clin Oncol. 2006 May 1;24(13):2098-104
16648512
Future Oncol. 2009 Sep;5(7):959-75
19792966
J Clin Oncol. 2004 Mar 1;22(5):777-84
14990632
Cancer Imaging. 2006 Oct 31;6:S126-30
17114065
PLoS One. 2009 Oct 30;4(10):e7670
19888321
N Engl J Med. 2004 May 20;350(21):2129-39
15118073
Science. 1998 Aug 21;281(5380):1191-3
9712583
Cancer J. 2009 Sep-Oct;15(5):406-20
19826361
Nat Biotechnol. 1999 Apr;17(4):375-8
10207887
Mol Imaging. 2009 Mar-Apr;8(2):101-10
19397855
Neoplasia. 2009 Jun;11(6):574-82, 1 p following 582
19484146
Nat Med. 2009 Aug;15(8):960-6
19597504
Eur J Radiol. 2010 Feb;73(2):420-7
19261416
Circulation. 2009 Aug 18;120(7):592-9
19652086
Eur J Cancer. 2009 Jan;45(2):261-7
19091550
Magn Reson Med. 2008 Apr;59(4):679-85
18302223
Magn Reson Med. 2008 Dec;60(6):1337-46
19025883
Nature. 2008 Jun 12;453(7197):940-3
18509335
Ann Surg. 2009 Nov;250(5):747-53
19826249
Nat Med. 2003 Oct;9(10):1269-74
14502282
Int J Cancer. 2002 Sep 10;101(2):151-5
12209992